[2]
Departamento de Dermatología, Universidad de Chile, Santiago, Chile. Departamento de Dermatología, Hospital Clínico San Borja Arriarán, Santiago, Chile
Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, et al. Current
perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis....
Iriarte C, Karim SA, Nassim JS, et al. Infantile Stevens Johnson
syndrome and toxic epidermal necrolysis: a systematic review
of clinical...
Iotti L, Caimmi S, Bottau P, et al. Clinical features, outcomes
and treatment in children with drug induced Stevens-Johnson
syndrome and toxic...
Jacobsen A, Olabi B, Langley A, et al. Systemic interventions
for treatment of Stevens-Johnson syndrome (SJS), toxic
epidermal necrolysis...
Cao J, Zhang X, Xing X, et al. Biologic TNF-α inhibitors for
Stevens-Johnson syndrome, toxic epidermal necrolysis,
and TEN-SJS overlap: a...
Huang DB, Wu JJ, Lahart CJ. Toxic epidermal necrolysis as a
complication of treatment with voriconazole. South Med J.
2004;97(11):1116–1117....
Curigliano G, Formica V, De Pas T, et al. Life-threatening toxic
epidermal necrolysis during voriconazole therapy for invasive
aspergillosis...
Gomulka J, Wilson BD, Joyce JC. Toxic epidermal necrolysis
due to voriconazole: Case report and review. Dermatol Online J.
2014;20(9). https://doi.org/10.5070/d3209023901.
Sachdeva M, Mufti A, Kim P, et al. Biologic treatment in
pediatric Stevens-Johnson syndrome/toxic epidermal
necrolysis: a systematic review....
Nguyen QD, Starling CT, Hebert AA. The use of TNF-α
inhibitors in treating pediatric skin disorders. Paediatr
Drugs. 2020;22(3):311–319. https://doi.org/10.1007/s40272-
020-00394-3.